Patents by Inventor Christopher Gabel

Christopher Gabel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240293065
    Abstract: Various systems and methods for managing disposable sensors and electrode gel are disclosed. According to an embodiment, a sensor assembly configured to be attached to a patient includes one or more electrode modules. Each of the one or more electrode modules includes an electrode, electrode gel disposed in a storage location on the electrode module, wherein electrode gel is not in contact with the electrode in the storage location, and a deformable cap configured to move the electrode gel from the storage location into contact with the electrode in response to a deformation of the deformable cap.
    Type: Application
    Filed: June 29, 2022
    Publication date: September 5, 2024
    Inventors: Christopher Gabel, Yanju Wang, Sean Walgrave, Christopher Ian Johnson, Robert Brendan Smith, Daniel Garcia
  • Patent number: 11731918
    Abstract: The present invention relates to a process for producing butadiene from ethanol, in two reaction steps, comprising a step a) of converting ethanol into acetaldehyde and a step b) of conversion into butadiene, said step b) simultaneously implementing a reaction step and a regeneration step in (n+n/2) fixed-bed reactors, n being equal to 4 or a multiple thereof, comprising a catalyst, said regeneration step comprising four successive regeneration phases, said step b) also implementing three regeneration loops.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: August 22, 2023
    Assignees: IFP Energies nouvelles, COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
    Inventors: Kirill Drobyshev, Rejane Dastillung, Jean-Christophe Gabelle, Matthieu Rolland
  • Publication number: 20230190162
    Abstract: A surface electrode for patient monitoring includes a flexible substrate, a dry electrode on the substrate, and a wet electrode configured to contact an electrode gel in contact with a patient's skin. A conductive epoxy is arranged between the dry electrode and the wet electrode. The conductive epoxy is configured to protect the dry electrode from corrosion and transfer electrical potentials from the wet electrode to the printed dry electrode.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 22, 2023
    Applicant: GE Precision Healthcare LLC
    Inventors: Stephen M. Crynock, Christopher Gabel, Yanju Wang, Sean R. Walgrave, Dennis A. Sauer
  • Patent number: 11453853
    Abstract: The present invention relates to a process for cleaning a solid support of a fermentation reactor for the production of alcohols by fermentation using a sugary fluid, the solid support comprising a polyurethane foam inoculated with a biomass produced by a solvent-producing strain belonging to the genus Clostridium, the process comprising placing the solid support in contact with a fluid originating from the fermentation must enriched in alcohol and/or acetone and/or an aqueous solution at basic pH.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: September 27, 2022
    Assignee: IFP Energies Nouvelles
    Inventors: Helena Gonzalez Penas, Marcel Ropars, Eszter Toth, Belinda Perez Bibbins, Nicolas Lopes Ferreira, Vincent Coupard, Angelique Bisson, Jean-Christophe Gabelle
  • Patent number: 11401219
    Abstract: The present invention relates to a process for producing butadiene from ethanol, in two reaction steps, comprising a step a) of converting ethanol into acetaldehyde and a step b) of conversion into butadiene, said step b) simultaneously implementing a reaction step and a regeneration step in (n+n/2) fixed-bed reactors, n being equal to 2 or a multiple thereof, comprising a catalyst, said regeneration step comprising four successive regeneration phases, said step b) also implementing a regeneration loop for the inert gas and at least one regeneration loop for the gas streams comprising oxygen.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: August 2, 2022
    Assignees: IFP Energies nouvelles, COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
    Inventors: Kirill Drobyshev, Rejane Dastillung, Jean-Christophe Gabelle, Matthieu Rolland
  • Patent number: 11358911
    Abstract: A process for dehydrating an ethanol feedstock to give ethylene, includes: a) a vaporization stage; b) a heating stage; c) a dehydration stage in a multitubular reactor comprising tubes having a length of between 2 and 4 m, said tubes comprising a, preferably zeolitic, dehydration catalyst, the feedstock having an inlet temperature of greater than 400° C. and less than 550° C. and an inlet pressure of between 0.8 and 1.8 MPa, the heat transfer fluid having an inlet temperature of greater than 430° C. and less than 550° C. and a mass flow rate such that the ratio of the mass flow rates of the heat transfer fluid relative to the feedstock is greater than or equal to 10; d) separation into an effluent comprising ethylene and an aqueous effluent; e) purification of the aqueous effluent and separation of a stream of purified water and a stream of unconverted ethanol.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: June 14, 2022
    Assignees: IFP Energies nouvelles, TOTAL RESEARCH & TECHNOLOGY FELUY
    Inventors: Kirill Drobyshev, Vincent Coupard, Nikolai Nesterenko, Jean-Christophe Gabelle
  • Patent number: 11159890
    Abstract: An acoustic receiver includes a first receiver subassembly having a bottom housing plate with a motor assembly fastened thereto, and a second receiver subassembly having a closed-ended receiver housing sidewall fastened to the bottom housing plate that includes at least one sidewall opening where a portion of the acoustic receiver is disposed in the at least one sidewall opening.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: October 26, 2021
    Assignee: Knowles Electronics, LLC
    Inventors: Yahui Zhang, Shehab Albahri, Christopher Gabel
  • Publication number: 20210120341
    Abstract: An acoustic receiver includes a first receiver subassembly having a bottom housing plate with a motor assembly fastened thereto, and a second receiver subassembly having a closed-ended receiver housing sidewall fastened to the bottom housing plate that includes at least one sidewall opening where a portion of the acoustic receiver is disposed in the at least one sidewall opening.
    Type: Application
    Filed: October 18, 2019
    Publication date: April 22, 2021
    Inventors: Yahui Zhang, Shehab Albahri, Christopher Gabel
  • Patent number: 10604456
    Abstract: This invention relates to a method for dehydration of alcohols into olefins comprising an improved step for recovery of unreacted alcohol.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: March 31, 2020
    Assignees: TOTAL RESEARCH & TECHNOLOGY FELUY, IFP Energies nouvelles
    Inventors: Kirill Drobyshev, Vincent Coupard, Jean-Christophe Gabelle, Nikolai Nesterenko, Christophe Thille
  • Publication number: 20190387321
    Abstract: In accordance with one aspect, a diaphragm for an acoustic receiver is provided that includes a frame, a paddle flexibly coupled to the frame, and a gap between a portion of the paddle and the frame. The diaphragm further includes siloxane material coupled to at least a portion of the paddle and to at least a portion of the frame. The siloxane material covers the gap. In another aspect, a method is provided for making an acoustic receiver diaphragm.
    Type: Application
    Filed: February 9, 2018
    Publication date: December 19, 2019
    Inventors: Paul Dayton, Christopher Monti, Jose Salazar, Shehab Albahri, Daniel Warren, Charles King, Christopher Gabel
  • Publication number: 20160137708
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Application
    Filed: January 22, 2016
    Publication date: May 19, 2016
    Applicant: Amgen Inc.
    Inventors: John E. Sims, Blair R. Renshaw, Christopher Gabel, Jennifer E. Towne, Randal R. Ketchum
  • Publication number: 20150017123
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Application
    Filed: September 22, 2014
    Publication date: January 15, 2015
    Inventors: John E. SIMS, Blair R. RENSHAW, Christopher GABEL, Jennifer E. TOWNE, Randal R. KETCHEM
  • Patent number: 8871192
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: October 28, 2014
    Assignee: Amgen Inc.
    Inventors: John E. Sims, Blair R. Renshaw, Christopher Gabel, Jennifer E. Towne, Randal R. Ketchem
  • Patent number: 8725645
    Abstract: A non-invasive metering system enables on-demand, metered usage licensing of software applications. A packaging module generates a secure application package for an original, unmodified application authored by a software publisher. The software publisher need not directly modify the code of the original application. Rather, the packaging module includes, within the secure application package but separate from the code of the application itself, a shell application that controls runtime aspects of the application, such as metering of the application. The secure application package is made available to users wishing to use the application on a metered basis.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: May 13, 2014
    Assignee: Cetrus LLC
    Inventors: Cory A. Montini, Uri Eliahu, David E. Lieberman, Christopher Gabel
  • Publication number: 20130336926
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Application
    Filed: June 11, 2013
    Publication date: December 19, 2013
    Applicant: Amgen Inc.
    Inventors: John E. SIMS, Blair R. RENSHAW, Christopher GABEL, Jennifer E. TOWNE, Randal R. KETCHEM
  • Patent number: 8481021
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: July 9, 2013
    Assignee: Amgen Inc.
    Inventors: John E Sims, Blair R Renshaw, Christopher Gabel, Jennifer E. Towne, Randal R Ketchem
  • Publication number: 20120020918
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Application
    Filed: September 2, 2011
    Publication date: January 26, 2012
    Applicant: Amgen Inc.
    Inventors: John E. Sims, Blair R. Renshaw, Christopher Gabel, Jennifer E. Towne, Randal R. Ketchem
  • Patent number: 8034771
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: October 11, 2011
    Assignee: Amgen Inc.
    Inventors: John E. Sims, Blair R. Renshaw, Christopher Gabel, Jennifer E. Towne, Randal R. Ketchem
  • Publication number: 20080241096
    Abstract: The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
    Type: Application
    Filed: September 10, 2007
    Publication date: October 2, 2008
    Applicant: Amgen Inc.
    Inventors: John E. Sims, Blair R. Renshaw, Christopher Gabel, Jennifer E. Towne, Randal R. Ketchem
  • Publication number: 20060018904
    Abstract: This invention provides methods of treatment of IL-1 mediated diseases comprising administering a pharmaceutically effective amount of a pharmaceutical agent selected from the group of sulfasalazine, a statin, a glucocorticoid agent, an inhibitor of p38 kinase, an anti-IL-6-receptor antibody, anakinra, an IL-1 monoclonal antibody, an inhibitor of JAK3 protein tyrosine kinase, a M-CSF monoclonal antibody or a humanized anti-CD20 monoclonal antibody and a benzamide inhibitor of the P2X7 receptor of the formula: wherein R1-R3 are as defined herein. The methods of the invention are useful in the treatment of IL-1 mediated disorders, including, without limitation, inflammatory diseases such as osteoarthritis and rheumatoid arthritis; allergies, asthma, COPD, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Inventors: James Chung, Christopher Gabel, Gail Jungbluth